Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and Budd-Chiari Syndrome

dabigatran has been researched along with Budd-Chiari Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Aigner, E; Balcar, L; Bartl, S; Datz, C; Gensluckner, S; Hametner-Schreil, S; Hofer, H; Lampichler, K; Lindorfer, A; Mandorfer, M; Pomej, K; Reiberger, T; Schäfer, B; Scheiner, B; Schöfl, R; Semmler, G; Trauner, M; Zoller, H1
Gamanagatti, SR; Kumar, R; Rout, G; Sharma, S1
Husová, L1

Other Studies

3 other study(ies) available for dabigatran and Budd-Chiari Syndrome

ArticleYear
Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:4

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Austria; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Dabigatran; End Stage Liver Disease; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Retrospective Studies; Severity of Illness Index; Vitamin K

2023
Dabigatran as an oral anticoagulant in patients with Budd-Chiari syndrome post-percutaneous endovascular intervention.
    Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:4

    Topics: Adult; Anticoagulants; Budd-Chiari Syndrome; Dabigatran; Endovascular Procedures; Female; Follow-Up Studies; Humans; Male; Retrospective Studies; Stents; Vitamin K; Young Adult

2020
Use of idarucizumab in clinical practice: a case report.
    Vnitrni lekarstvi, 2019,Spring, Volume: 65, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Budd-Chiari Syndrome; Dabigatran; Hemorrhage; Humans; Liver Transplantation

2019